Jonathan Stine, MD
Enriched profileProfessor of Medicine and Public Health Sciences · Pennsylvania State University College of Medicine
Jonathan Stine is Professor of Medicine and Public Health Sciences at Pennsylvania State University College of Medicine. OpenAlex indexes 178 publications with 5,277 citations (h-index 35); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Jonathan Stine, MD, is Professor of Medicine and Public Health Sciences at Pennsylvania State University College of Medicine (Penn State Health Milton S. Hershey Medical Center). The public record shows 178 publications with 5,277 citations (h-index 35), centered on Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2022–2025).
- Most recent indexed publication: 2025 · Journal of clinical medicine
- Top research focus: Liver Disease Diagnosis and Treatment
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 71.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH
Sponsor: Milton S. Hershey Medical Center
- NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal
Sponsor: Milton S. Hershey Medical Center
- NASH Fitness Intervention in Thrombosis Trial (NASHFit)
Sponsor: Milton S. Hershey Medical Center
Industry payments
Updated 27 Aug 2026
4 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202510 payments
- AstraZeneca Pharmaceuticals LPProgram year20245 payments
- Madrigal PharmaceuticalsProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
38.9%Rifamycin Antibacterial12.6%Xifaxan100%Part D<11 patientsProton pump inhibitor9%Omeprazole100%Part D<11 patientsCancer & immunology
26.3%Calcineurin inhibitor23.7%Tacrolimus89%Gengraf11%Part D<11 patientsKinase inhibitor2.6%Everolimus100%Part D<11 patientsCardiovascular
23.5%Beta blocker15.2%Carvedilol100%Part D≥12 patientsAldosterone antagonist (MRA)4.5%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis
Pennsylvania State Univ Hershey Med Ctr
FY2025$200,135K23DK131290 - Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis
Pennsylvania State Univ Hershey Med Ctr
FY2024$200,135K23DK131290 - Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis
Pennsylvania State Univ Hershey Med Ctr
FY2023$200,135K23DK131290
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Does Continuous Positive Airway Pressure Improve Liver Outcomes in MASLD with Obstructive Sleep Apnea? A Systematic Review.
Journal of clinical medicine
Review2025 - Editorial: Chrononutrition and MASLD-Its About Time (Restricted Feeding)!
Alimentary pharmacology & therapeutics
Editorial2025 - Aerobic exercise interventions lead to MASH resolution in clinical trials: Pooled analysis using the MASH resolution index.
Hepatology communications
Article2025 - Multidisciplinary clinic model enhances liver and metabolic health outcomes in adults with MASH.
Hepatology communications
Article2025
Most-cited works
by citation count (OpenAlex)- 01Bile acids and the gut microbiota: metabolic interactions and impacts on diseaseArticle1,135 citations2022
- 02
- 03
- 04Review article: prescribing medications in patients with cirrhosis – a practical guideArticle212 citations2013
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jonathan-stine-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
hmc.pennstatehealth.org/display-provider/-/provider/3304/jonathan-g-stine-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hmc.pennstatehealth.org ↗ - Other
pennstate.pure.elsevier.com/en/persons/jonathan-stine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstate.pure.elsevier.com ↗
Mentions by others
where others cite or feature them- Other
pennstatehealthnews.org/topics/stine-shares-liver-research-findings-in-gastroenterology-podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealthnews.org ↗ - Other
shows.acast.com/the-dr-joe-galati-podcast/episodes/jonathan-stine-fatty-liver-research
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →shows.acast.com ↗ - Other
aasld.org/the-liver-meeting/speakers/jonathan-g-stine-76963
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.psu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.psu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.psu.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.psu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Secondary affiliations
appointments beyond the home institution- Penn State Cancer Institute
Cancer Control Program (Fatty Liver Program Director; former Liver Center Director of Research)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.psu.edu ↗
Media & interviews
press, podcasts and appearances- "Jonathan Stine, M.D.: Fatty Liver and Exercise" - guest
The Dr. Joe Galati Podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
- Research on fatty liver disease and exercise covered by ABC
Associated Press, NPR, Yahoo, and STAT News
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.